Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|January 3, 2021
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paperAlessandro Busca, Chiara Cattaneo, Elena De Carolis, et al.
Blood Advances|November 21, 2022
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNBDaniela Clerici, Laura Galli, Raffaella Greco, et al.
Haematologica|October 6, 2022
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantationElena Tassi, Maddalena Noviello, Pantaleo De Simone, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2020
Do high MICs predict the outcome in invasive fusariosis?Marcio Nucci, Jeffrey Jenks, George R Thompson, et al.
Annals of Hematology|May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life studyLuana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Cancers|July 14, 2023
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM ExperienceLuana Fianchi, Fabio Guolo, Francesco Marchesi, et al.
Haematologica|March 19, 2026
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasoneCarmine Liberatore, Alfonso Piciocchi, Donatella Vincelli, et al.
Haematologica|March 26, 2026
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experienceCarmine Liberatore, Virginia Valeria Ferretti, Paola Tacchetti, et al.
Nature Medicine|June 1, 2026
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 5, 2023
Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel RecommendationsHarris A Eyre, Lucy E Stirland, Dilip V Jeste, et al.
Pageof 14